544220 — Clinitech Laboratory Income Statement
0.000.00%
Last trade - 00:00- IN₹103.05m
- IN₹57.20m
- IN₹64.03m
Annual income statement for Clinitech Laboratory, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 45.5 | 63.8 | 63.5 | 64 |
| Cost of Revenue | ||||
| Gross Profit | 35.4 | 49.4 | 51.8 | 53 |
| Selling / General / Administrative Expenses | ||||
| Depreciation and Amortization | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 39.6 | 56.4 | 54.4 | 58.4 |
| Operating Profit | 5.9 | 7.4 | 9.09 | 5.67 |
| Gain / Loss on Sale of Assets | ||||
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | 5.46 | 7.02 | 8.64 | 5.05 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | 4.02 | 5.13 | 6.13 | 3.71 |
| Net Income Before Extraordinary Items | ||||
| Net Income | 4.02 | 5.13 | 6.13 | 3.71 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | 4.02 | 5.13 | 6.13 | 3.71 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | 1.76 | 2.25 | 2.69 | 1.59 |
| Dividends per Share |